Trial ID: | L0441 |
Source ID: | ChiCTR2000029144
|
Associated Drug: |
Danggui Shaoyao Powder
|
Title: |
Study for effect of classic prescription Danggui Shaoyao Powder in the treatment of Wet-stasis syndrome Non-alcoholic Fatty Liver Disease
|
Acronym: |
--
|
Status: |
Not Recruiting
|
Study Results: |
No Results Available
|
Results: |
--
|
Conditions: |
Nonalcoholic fatty liver disease
|
Interventions: |
Experimental group:Danggui Shaoyao powder granule;Control group:Danggui Shaoyao powder granule simulant;
|
Outcome Measures: |
MRI-PDFF;serum activity of ALT;Abdominal Fibroscan CAP;weight;BMI;waistline;serum activity of AST;serum activity of GGT;serum levels of TC;fasting blood-glucose;fasting insulin;insulin resistance index;SF-36;TCM Syndrome Points;serum levels of TG;serum levels of HDL-C;serum levels of LDL;
|
Sponsor/Collaborators: |
Shuguang Hospital affiliated to Shanghai University of TCM
|
Gender: |
All
|
Age: |
1865
|
Phases: |
Not applicable
|
Enrollment: |
Experimental group:56;Control group:56;
|
Study Type: |
Interventional study
|
Study Designs: |
Parallel
|
Start Date: |
15/01/2020
|
Completion Date: |
--
|
Results First Posted: |
--
|
Last Update Posted: |
20 January 2020
|
Locations: |
China
|
URL: |
http://www.chictr.org.cn/showproj.aspx?proj=48258
|